Showing results (1321-1330 of 1,495) with videos related to
Sort By:
Pageof 150
Nature|June 3, 2026
A natural depsipeptide antibiotic binds the E-site of the bacterial ribosomeManpreet Kaur, Dmitrii Y Travin, Max J Berger, et al.Frontiers in Genetics|March 7, 2022
An Epigenetic Alphabet of Crop Adaptation to Climate ChangeFrancesco Guarino, Angela Cicatelli, Stefano Castiglione, et al.Urologic Oncology|February 23, 2013
Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional studyG Verhoest, J J Patard, E Oger, et al.World Journal of Urology|November 26, 2013
Is there a volume-outcome relationship for partial nephrectomy?J-P Couapel, K Bensalah, J-C Bernhard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patientsC H Takimoto, G Morrison, N Harold, et al.The Journal of Antimicrobial Chemotherapy|November 26, 2010
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporinsM E A de Kraker, M Wolkewitz, P G Davey, et al.Biorxiv : the Preprint Server for Biology|September 11, 2024
Extensive transmission and variation in a functional receptor for praziquantel resistance in endemic <i>Schistosoma mansoni</i>Duncan J Berger, Sang-Kyu Park, Thomas Crellen, et al.World Journal of Urology|November 7, 2014
The accuracy of renal tumor biopsy: analysis from a national prospective studyJ C Bernhard, P Bigot, G Pignot, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2017
NCCN Guidelines Insights: Antiemesis, Version 2.2017Michael J Berger, David S Ettinger, Jonathan Aston, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.Pageof 150